Setting a gold standard in meeting cannabis regulation

Medical Cannabis Network speaks with Bird & Bird’s Ben King and Sally Shorthose about the importance of product labelling and the regulation of medical cannabis.

Bird & Bird know that the issue of labelling medical cannabis products can be a confusing and challenging issue for new market entrants. It is important that the product be clearly classified as being either medicinal or recreational. The labelling of some products has been exploited, allowing them to be marketed as something they are not and undermining consumer confidence in the product.

 

Latest insights

More Insights
cipa

Payments contracts: a guide to gateway and acquiring services for in-house counsel

Apr 29 2024

Read More

Big tech in finance: 'Big tech a priority' says FCA

Apr 29 2024

Read More
EU Flag

The reform on the protection of geographical indications in the European Union

Apr 29 2024

Read More